Tandem Diabetes Care Inc (FRA:TD5A)
€ 46.5 -0.61 (-1.29%) Market Cap: 3.09 Bil Enterprise Value: 3.10 Bil PE Ratio: 0 PB Ratio: 13.74 GF Score: 77/100

Tandem Diabetes Care Inc at Jefferies London Healthcare Conference Transcript

Nov 15, 2022 / 12:20PM GMT
Release Date Price: €40.47 (+5.49%)
Unidentified Analyst

Running the Tandem Diabetes fireside chat. My name is [Young Li]. I'm one of the analysts on the U.S. Medtech team. I'm very pleased to be joined by John Sheridan, President and CEO; and Leigh Vosseller, EVP, CFO and Treasurer.

Thanks for coming to our conference, guys and looking forward to the chat. So I guess maybe we can spend a minute just talking about the insulin pump market, penetration of the opportunity today? And where do you think this therapy is going over time?

Questions & Answers

John F. Sheridan
Tandem Diabetes Care, Inc. - President, CEO & Director

Sure. Well, first of all, it's nice to be here. I would say that if you look back over the last couple of years, the insulin pump market has been accelerating. If you were to go back as far as 5 or 6 years ago, there was about 25,000 people, who came from MDI therapy annually to pump therapy. And around 2018, we saw that started to accelerate. I think it was largely driven by new technologies in the marketplace, technologies that reduce the burden of diabetes

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot